The TLR3 Agonist Inhibit Drug efflux and Sequentially...

  • Main
  • 2017 / 01
  • The TLR3 Agonist Inhibit Drug efflux and Sequentially...
Molecular Cancer Therapeutics 2017 / 01

The TLR3 Agonist Inhibit Drug efflux and Sequentially Consolidates Low-dose Cisplatin-based Chemoimmunotherapy while Reducing Side effects

Ding, Liang, Ren, Jing, Zhang, Dongya, Li, Yi, Huang, XiaoFeng, Ji, Jianjian, Hu, Qingang, Wang, Hui, Ni, Yanhong, Hou, Yayi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-16-0454
Date:
January, 2017
File:
PDF, 5.92 MB
english, 2017
Conversion to is in progress
Conversion to is failed